OrbiMed Advisors »

Palvella Therapeutics Inc Ne shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $23M 185k 124.65

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Avita Therapeutics (RCEL)
Mdxhealth Sa Shs New Call Option (MDXH)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Boston Scientific Corporation (BSX)
Sionna Therapeutics (SION)
Astrazeneca Ord (AZN)
Myriad Genetics (Principal) (MYGN)
Mbx Biosciences (MBX)
Corvus Pharmaceuticals (CRVS)
Argenx Se Sponsored Adr (ARGX)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)

View all positions for OrbiMed Advisors

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Group
Vanguard Capital Management
Federated Investors
State Street Corporation
Summit Partners Public Asset Management
Woodline Partners
Alliancebernstein
FMR
MPM Oncology Impact Management

View all funds holding Palvella Therapeutics Inc Ne